Characterize and Assess Clinical Outcomes of Patients Receiving Tezepelumab After Marketing Approval in Spain

RecruitingOBSERVATIONAL
Enrollment

400

Participants

Timeline

Start Date

June 23, 2025

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
Asthma
Trial Locations (16)

Unknown

NOT_YET_RECRUITING

Research Site, Andalucia

ACTIVE_NOT_RECRUITING

Research Site, Andalucia

RECRUITING

Research Site, C. Valenciana

ACTIVE_NOT_RECRUITING

Research Site, C. Valenciana

NOT_YET_RECRUITING

Research Site, C. Y Leon

NOT_YET_RECRUITING

Research Site, Cantabria

NOT_YET_RECRUITING

Research Site, Castilla La Mancha

NOT_YET_RECRUITING

Research Site, Cataluna

ACTIVE_NOT_RECRUITING

Research Site, Cataluna

NOT_YET_RECRUITING

Research Site, Extremadura

NOT_YET_RECRUITING

Research Site, Galicia

NOT_YET_RECRUITING

Research Site, Islas Canarias

NOT_YET_RECRUITING

Research Site, Navarra

NOT_YET_RECRUITING

Research Site, Pais Vasco

NOT_YET_RECRUITING

Research Site, Madrid

ACTIVE_NOT_RECRUITING

Research Site, Madrid

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AstraZeneca

INDUSTRY